共 83 条
- [1] Heidenreich A(2014)EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer Eur Urol 65 467-79
- [2] Bastian PJ(1995)Survival and quality of life of patients with stage d1 (t1-3 pn1-2 m0) prostate cancer. Radical prostatectomy plus androgen deprivation versus androgen deprivation alone Eur Urol 27 202-6
- [3] Bellmunt J(2013)Management of lymph node-positive prostate cancer: the role of surgery and radiation therapy Oncology (Williston Park, NY) 27 647-55
- [4] Bolla M(2010)Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer Eur Urol 57 754-61
- [5] Joniau S(2011)Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study BJU Int 107 1755-61
- [6] van der Kwast T(2007)Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era J Urol 178 864-70
- [7] Frohmuller HG(2003)Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 169 849-54
- [8] Theiss M(2011)Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pt2-4 pn+ prostate cancer: results of a matched analysis Eur Urol 59 832-40
- [9] Manseck A(2006)Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy Lancet Oncol 7 472-9
- [10] Wirth MP(2013)Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and gleason score BJU Int 111 1237-44